The Dutch Medical Research Involving Human Subjects Act (WMO) limits non-therapeutic research in children by means of the absolute requirement of negligible risk and minimal burden. The European Clinical Trials Directive, however, allows clinical research with medicinal products in children when, among other requirements, the investigation has any direct benefit for the group of patients involved. In addition, pain, discomfort, fear and other anticipated risks should be minimised. This European Directive has been implemented in the WMO, but the Dutch restriction on non-therapeutic research with children was not adjusted. An expert committee has now advised the Dutch government to bring the WMO in line with the Clinical Directive for all forms of medical interventional and observational research involving children, except for observational studies in children younger than 12 years. In these children, the strict limits of minimal risk and burden should be maintained.
Download full-text PDF |
Source |
---|
J Med Ethics
January 2025
Philosophy, University of Waterloo, Waterloo, Ontario, Canada
How should defenders of liberalism think about access to reproductive technologies? Mitochondrial replacement technique (MRT) enables women with pathogenic variations of mitochondrial disease to have children without the fear of transmission. This technology can also allow lesbians, or partners with female-assigned physiology (PFP), to have genetically related offspring. Cavaliere and Palacios-Gonzalez argue that lesbians should be able to access MRT on autonomy grounds.
View Article and Find Full Text PDFCult Health Sex
January 2025
Department of Psychology, Staffordshire University, Stoke-on-Trent, UK.
There is increasing recognition of the need to address the diverse experiences of individuals subjected to medically unnecessary, non-voluntary genital cutting in childhood. This includes children with intersex traits undergoing 'normalisation' surgeries and those with anatomically normative genitalia, such as female genital cutting or male circumcision. While most research on non-therapeutic childhood penile circumcision centres on the physical risks and benefits, far less attention has been given to the potential long-term mental health impacts, particularly from a psychotherapeutic perspective.
View Article and Find Full Text PDFZhongguo Dang Dai Er Ke Za Zhi
August 2024
Department of Neonatology, Women and Children's Hospital, School of Medicine, Xiamen University/Xiamen Maternal and Child Health Hospital/Xiamen Key Laboratory of Perinatal-Neonatal Infection/Xiamen Clinical Research Center for Perinatal Medicine, Xiamen, Fujian 361003, China.
Transplant Cell Ther
October 2024
Department of Clinical Pharmacy, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Busulfan exposure has previously been linked to clinical outcomes, hence the need for therapeutic drug monitoring (TDM). Study objective was to evaluate the effect of day 1 TDM-guided dosing (regimen d1) versus days 1 + 2 TDM-guided dosing (regimen d1 + 2) on attaining adequate busulfan exposure. In this observational study, we included all adults who received an allogeneic HCT with intravenous once daily busulfan over 4 days as part of the conditioning regimen at the University Medical Centre Utrecht or between July 31, 2014 and November 12, 2021.
View Article and Find Full Text PDFObjectives: To reduce the overuse of magnetic resonance cholangiopancreatography and the rates of non-therapeutic endoscopic retrograde cholangiopancreatography in pediatric patients suspected of choledocholithiasis.
Materials And Methods: Retrospective study of patients suspected of choledocholithiasis between January 2010 and June 2023. Patients with cholangitis or two or more of the following predictive factors of choledocholithiasis in initial laboratory tests and ultrasound were categorized as high-risk group: total bilirubin level ≥ 2 mg/dl, common bile duct > 6 millimeters on ultrasound; and detection of choledocholithiasis by ultrasound.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!